Clinical Trial Update: Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating preoperative docetaxel alone or with cisplatin for C-stage IB-II non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Haruhiko Fukuda | Conditions: Pulmonary Neoplasms | Phase 2 | Status: COMPLETED